Skip to content
Clinical Trials – home

Spitalul Clinic De Obstetrica Ginecologie Cuza Voda Iasi

Verified siteinfo

Romania Strada Cuza Voda Nr.34, 700038 Iasi, Romania

  • Bacterial vaginosis · Respiratory syncytial virus infection · Retinopathy of prematurity
  • Adults and children

About Specializations

Spitalul Clinic De Obstetrica Ginecologie Cuza Voda Iasi in Iasi, Romania specialises in clinical trials of conditions such as Bacterial vaginosis, Respiratory syncytial virus infection, Retinopathy of prematurity, Vulvovaginal candidiasis, and other specialisations. This site conducts important research.

Main research areas of the site

Neonatology and Infant Respiratory Protection

At Spitalul Clinic De Obstetrica Ginecologie Cuza Voda Iasi, clinical research in neonatology includes studies focused on respiratory syncytial virus prevention in healthy infants. These trials are designed to assess whether a new preventive approach can reduce serious RSV-related lower respiratory infections while maintaining good safety and tolerability.

  • Prevention of RSV in infants
  • Evaluation of infection prevention and safety in early life
  • Research aimed at lowering medically attended respiratory illness

This work highlights the site’s interest in protecting newborns and young infants from common viral respiratory threats.

Eye Disease Research in Prematurity

The site also contributes to eye disease research through studies on retinopathy of prematurity, a serious condition affecting some preterm babies. The main goal is to follow long-term safety outcomes and visual function, helping determine how well treatment benefits may persist over time.

  • Retinopathy of prematurity
  • Long-term vision and safety follow-up
  • Research supporting better outcomes for premature infants

This area reflects an important focus on preserving vision and improving care for vulnerable newborns.

Women’s Health and Vaginal Infections

In female urogenital diseases, the research landscape includes trials for bacterial vaginosis and vulvovaginal candidiasis. These studies compare established treatments to better understand which options provide the most effective clinical and microbiological cure for women with vaginitis.

  • Bacterial vaginosis and vulvovaginal candidiasis
  • Treatment effectiveness in specific and non-specific vaginitis
  • Comparison of therapies used for vaginal infection control

This research supports improved management of common gynecological infections and aims to guide practical treatment choices in everyday care.

Infection and Immune-Related Clinical Research

Across its trial portfolio, the site also engages with bacterial infections and mycoses alongside immune system processes. These studies explore how preventive and therapeutic strategies can reduce infection burden and support better health outcomes in both infants and adult women.

  • Bacterial infections and fungal infections
  • Infection prevention and treatment response
  • Clinical research aimed at improving patient care

The work at this hospital-based research site shows a practical focus on common infectious conditions and their impact on vulnerable patient groups.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Cuza Voda Nr.34700038 IasiRomania
Recruiting now
no trials
Conditions studied
4
Partner status
Verified site

More sites in IasiRomania

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Vulvovaginal candidiasis+1

Not yet recruiting

Study on the Effectiveness and Safety of Metronidazole, Neomycin Sulfate, and Nystatin for Women with Bacterial Vaginosis and Yeast Infections

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Metronidazole
  • Sponsor:Antibiotice S.A.

Study on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years · Healthy volunteers
  • Sponsor:Merck Sharp & Dohme LLC

Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Aflibercept
  • Sponsor:Bayer AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.